Drug or treatment

Emapalumab clinical trials

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Emapalumab for MDA5-positive RP-ILD in adults

  This study tests whether emapalumab can help adults with anti-MDA5 positive rapidly progressive interstitial lung disease who have dermatomyositis-related conditions.

  Recruiting Phase 2 University of Miami · Miami, Florida · NCT07486869

• Preventing graft rejection after allogeneic stem cell transplant

  This trial will try the drug emapalumab to see if it can prevent graft rejection in people judged high risk after allogeneic hematopoietic stem cell transplant.

  Recruiting Early Phase 1 Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07244419

• Randomized stepped-wedge testing emapalumab for APECED enteritis

  This trial will test whether emapalumab can lessen gastrointestinal symptoms in people with APECED-related enteritis.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07202598

• Adding emapalumab to standard post-transplant medicines to prevent graft‑versus‑host disease after reduced‑intensity donor stem cell transplant

  This trial will test whether adding emapalumab to post‑transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil can prevent graft‑versus‑host disease in adults with AML or MDS receiving a reduced‑intensity donor stem cell transplant.

  Recruiting Phase 1 City of Hope Medical Center · Duarte, California · NCT06996119

• Preventing CAR-T cell toxicities with emapalumab

  This study is testing if a drug called emapalumab can help prevent side effects in people with large B-cell non-Hodgkin's lymphoma who are receiving another treatment called axicabtagene ciloleucel.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts and 1 other locations · NCT06550141

• Emapalumab treatment for pediatric aplastic anemia

  This study is testing if a new treatment called emapalumab can help children with severe aplastic anemia do better with their standard treatments.

  Recruiting at 5 sites Phase 2 Memorial Sloan Kettering Cancer Center · New York, New York and 5 other locations · NCT06430788

• Treatment of prolonged severe cytopenia after CAR T-cell therapy

  This study is testing if a new treatment called emapalumab can help people with large B-cell lymphoma who have low blood cell counts after CAR T-cell therapy feel better and recover.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT06285825

Quick answers

How many clinical trials of Emapalumab are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →